INCREASED OXIDATIVE STRESS REDUCES THE LEVEL OF SERUM PARAOXONASE-1(PON-1) AND OTHER BIOCHEMICAL MARKERS IN PATIENTS WITH PULMONARY TUBERCULOSIS (PTB) IN NEPALESE POPULATION.
- Department of Biochemistry, Gandaki Medical College & Teaching Hospital, Pokhara.
- Department of Microbiology, School of Medical Sciences, Kathmandu University.
- Department of Nursing, Charak Academy, Pokhara.
- Fishtail Hospital & Research Centre, Pokhara.
- Department of Microbiology, Gandaki Medical College & Teaching Hospital, Pokhara.
- College of Applied Medical Sciences, Al Jouf University, Al Qurayyat, Saudi Arabia.
- Department of Biochemistry, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal.
28 Downloads
261 Views
Abstract
Objectives: The aim of this study was to assess the total peroxides level and paraoxonase (PON1) activities in patients with Pulmonary tuberculosis (PTB) in Nepalese population.
Material and methods: A total of 70 (40 newly diagnosed active PTB and 30 healthy control) subjects were recruited for this study. Anthropometric variables, total peroxide and PON1 activities were determined in control and PTB subjects. Serum glucose, urea, total protein, albumin, globulin and uric acid levels were also determined in the participants.
Results: Significant difference in BMI, SBP and DBP was observed between PTB and control subjects (p<0.001, p<0.01 and p<0.01 respectively). Total protein, albumin, TC and HDL were significantly lower in PTB subjects (p<0.05, p <0.001, p<0.01 and p<0.01 respectively). TG and LDL levels were also decreased though not statistically significant. However, the level of uric acid and globulin were significantly increased (p<0.01, p<0.001 respectively).The levels of Total peroxides (µmol H2O2/litre) activity in patients and control were 16.17±0.29 and 12.69±0.32, respectively (p=<0.001). Similarly, the levels of PON1 activity (µmol/min/ml) in patients and control were 109.72±6.43 and 161.55±15.49, respectively (p=0.004).
Conclusions: According to this study, we conclude that patients with active PTB are exposed to potent oxidative stress and they have decreased PON1 activity. These predisposal factors play a role in the pathogenesis of pulmonary tuberculosis in a group of Nepalese population which needs more clarification.
Keywords: Active pulmonary tuberculosis; PON1 activity; Total oxidant status
Keywords
How to Cite This Article
Amar Nagila, Nirajan Bhusal, Reetu Koirala, Basant Kumar Tamrakar, Sanjib Mani Regmi, Gyanendra Gautam, Mahendra Prasad Bhatt and Dipendra Raj Pandeya. (2018); INCREASED OXIDATIVE STRESS REDUCES THE LEVEL OF SERUM PARAOXONASE-1(PON-1) AND OTHER BIOCHEMICAL MARKERS IN PATIENTS WITH PULMONARY TUBERCULOSIS (PTB) IN NEPALESE POPULATION., International Journal of Advanced Research (IJAR), 6 (04), 120-127, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6833
Corresponding Author
Article Analytics
References
- WHO Tuberculosis Factsheet; March 2010
- Nuermberger, E, Bishai, WR, Grosset, JH. Latent tuberculosis infection. Semin. Respir. Crit. Care Med. 2004; 25: 317-36.
- Gomez, JE, McKinney, JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb). 2004; 84:29-44.
- WHO (2004) Health Development in the South -East Asia Region: An Overview. World Health Organization, Geneva.
- Park K. Epidemiology of Communicable Disease. In: Park?s Textbook of Preventive and Social Medicine, Bhanol Publishers, India pp. 2002;137-150.
- Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study. BMC Infect Dis 2008; 8:8
- Ragunath RR, and Madhavi SP. Plasma oxidant antioxidant status in different respiratory disorder. Indian J. of Clinical Biochemistry.2006;21(2):161-4.
- Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
- Repine J. E, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group.?Am J Respir Crit Care Med.?1997;156:341-57.
- Reddy YN, Murthy SV, Krishna DR and Prabhakar MC. Role of free radicals and antioxidants in tuberculosis patients. Indian Journal of Tuberculosis. 2004; 51: 213-8.
- Cerutti PA and Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells. 1991; 3:1-7.
- Kocyigit A, Keles H, Selek S, Guzel S, Celik H and Erel O. Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutation Research. 2005; 585:71-8.
- Devici F and Ilhan N. Plasma malondialdehyde and serum trace element concentrations in patients with active pulmonary tuberculosis. Biological Trace Element Research. 2003; 95: 29-38.
- Rai, RR and Phadke, MS. Plasma Oxidant Antioxidant Status in Different Respiratory Disorder. Indian Journal of Clinical Biochemistry. 2006; 21:161-4.
- Jack, CIA, Jackson, M.J. and Hind, CRK. Circulating Markers of Free Radical Activity in Patients with Pulmonary Tuberculosis. Tubercle and Lung Disease. 1994; 75: 132-7.
- Plit, ML, Theron, A.J., Fickl, H., Van Rensburg, C.E., Pendel, S. and Anderson, R. Influence of Antimicrobial Chemotherapy and Smoking Status on the Plasma Concentrations of Vitamin C, Vitamin E, Beta Carotene, Acute Phase Reactants, Iron and Lipid Peroxides in Patients with Pulmonary Tuberculosis. The International Journal of Tuberculosis and Lung Disease. 1998; 2: 590-6.
- Li HL, Liu DP and Liang CC. Paraoxonase gene polymorphisms, oxidative stress and diseases. Journal of Molecular Medicine. 2003;81:766-79.
- James RW and Deakin SP. The importance of high density lipoproteins for paraoxonase 1 secretion, stability and activity. Free Radical Biology and Medicine. 2004; 37(12):1986-94.
- Aviram M, Rosenblat M: Paraoxonases 1, 2 and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304?1316
- Ramesh, Sudha K , Amareshwara M, Sameer R.M. Study of protein oxidation and antioxidants status in pulmonary tuberculosis patients. Intl J of Pharma and Bio Sciences. 2011;2:3,104-109
- Sasaki Y. Yamagishi F, Yasi T, Mizutani F. A case of pulmonary tuberculosis case with pancytopenia accompanied to bone marrow gelatinous transformation. Kekaku 1999;74 (4):361-4
- Akiibinu MO, Arinola OG, Ogunlewe JO and Onih EA. Non-enzymatic antioxidants and nutritional profiles in newly diagnosed pulmonary tuberculosis patients in Nigeria. African Journal of Biomedical Research. 2007; 10: 223-228.
- Harries AD, Thomas J, Chugh KS. Malnutrition in Africa patients with pulmonary tuberculosis. Hum Nutr Clin Nutr 1985; 39: 361-363.
- P?rez-Guzm?n C, Vargas MH, Salas-M?rtir C, Trejo-Santacruz T, Gallegos-Discua C, Flores-L?pez F. Lipidprofile in household contacts of patients with pulmonary tuberculosis. Rev Med Inst Mex Seguro Soc. 2008; 46:247-52.
- Volpato S, Palmieri E, Fellin R, Zuliani G. Acute phase markers are associated with reduced plasma lipid concentrations in a population of hospitalized elderly patients. Gerontology. 2000; 46: 22-7.
- Kwiatkowska S, Piasecka G, Zieba M and Piotrowski D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis. Respiratory Medicine. 1999;93(4):272-6.
- Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D and Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease.Clinical Biochemistry. 2006;39:794-803.
- Rozenberg O, Aviram M. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun 2006;351:492?8.
- Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis. 2006; 187:363-71.
- Seres I, Paragh G, Deschene E, Fulop Jr T and Khalol A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Experimental Gerontology. 2004; 39:59-66.
- Aviram M, Rosenblat, M Bisgaier CL, Newton RS, Primo-Parm SL and La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase. Journal of Clinical Investigation. 1998;101: 1581-90.
This work is licensed under a Creative Commons Attribution 4.0 International License.





